The Involvement of Muscarinic Receptor Subtypes in the Mediation of Hypothermia, Tremor, and Salivation in Male Mice
- 1 January 1994
- journal article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 74 (1) , 35-39
- https://doi.org/10.1111/j.1600-0773.1994.tb01070.x
Abstract
The potency of centrally administered non‐selective (atropine and N‐methyl scopolamine) and putatively selective muscarinic antagonists (pirenzepine, AF‐DX 116 and 4‐DAMP) in inhibition of oxotremorine‐induced hypothermia, tremor and salivation in male mice has been compared with their potencyin vitroin three functional systems, where muscarinic effects are mediated preferentially by M1(i.e. superior cervical ganglion), M2(i.e. atrium), and M3(i.e. ileum) receptors. Atropine, N‐methyl scopolamine and 4‐DAMP potently abolished the effects of oxotremorine. Pirenzepine abolished tremor and salivation, whereas hypothermia was antagonized partially only. AF‐DX 116 had but weak antagonistic effects. Atropine and N‐methyl scopolamine were potent antagonists in all threein vitrotest systems. High potency was also seen with 4‐DAMP, in particular in the ileum preparation. Pirenzepine showed its highest potency in the ganglion preparation. AF‐DX 116 was a weak and non‐selective antagonist in all threein vitropreparations. Our studies indicate that the muscarinic induction of tremor and salivation may be preferentially mediated by M3receptors whereas both M2and M3receptors may be involved in the mediation of hypothermia. However, the overall conclusion is that compounds with higher receptor subtype selectivity are needed.Keywords
This publication has 25 references indexed in Scilit:
- Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypesEuropean Journal of Pharmacology, 1992
- Cholinergic mechanisms in learning, memory and dementia: a review of recent evidenceTrends in Neurosciences, 1991
- The Families of Cognition EnhancersPharmacopsychiatry, 1989
- Cholinergic systems and alzheimer's diseaseDrug Development Research, 1988
- Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepineLife Sciences, 1987
- MUSCARINIC RECEPTOR SUBTYPES: A CRITIQUE OF THE CURRENT CLASSIFICATION AND A PROPOSAL FOR A WORKING NOMENCLATUREJournal of Autonomic Pharmacology, 1986
- Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonistLife Sciences, 1986
- Action of agonists and antagonists at muscarinic receptors present on ileum and atria in vitroBritish Journal of Pharmacology, 1985
- A search for selective antagonists at M2 muscarinic receptorsBritish Journal of Pharmacology, 1985
- Central administration of the muscarinic receptor subtype - selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouseJournal of Pharmacy and Pharmacology, 1983